Furthermore, to assess the impact of METTL16 on the FBXO5 mRNA’s stability, after knockdown of METTL16, the BC cells were treated with actinomycin D for 0, 2, 4, 6, 8 h, respectively. The gene discussed is FBXO5; the disease is breast cancer.